The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers
Niklas Mattsson(Malmö University), Richard O’Brien(Duke University), A. Zara Herskovits(Massachusetts General Hospital), Staffan Persson(University of Copenhagen), Mathias Jucker(University of Basel), Marc Mercken(Janssen (Belgium)), Sat Dev Batish, William Nowatzke(Worldwide Clinical Trials (United States)), John C. McAuliffe(Albert Einstein College of Medicine), Albert Lladó(Hospital Clínic de Barcelona), Anne M. Fagan(Washington University in St. Louis), María C. Carrillo(Brigham and Women's Hospital), Sonia Chalbot(New York State Office for People With Developmental Disabilities), Aase Handberg(Aarhus University Hospital), Markus P. Kummer(University of Bonn), Christian Humpel(Innsbruck Medical University), José Luís Molinuevo(Pasqual Maragall Foundation), Harald Hampel(Sorbonne Université), Davide Chiasserini(University of Perugia), Stephan A. Kaeser(Hertie Institute for Clinical Brain Research), Orestes Vicente Forlenza(Universidade de São Paulo), Colin L. Masters(Mental Health Research Institute), Piotr Lewczuk(Universitätsklinikum Erlangen), Giovanni B. Frisoni(University of Geneva), Stefan Duller, Sanna‐Kaisa Herukka(University of Eastern Finland), Ulf Andréasson(Sahlgrenska University Hospital), Péter Klivènyi(University of Szeged), Luisella Bocchio‐Chiavetto(Centro San Giovanni di Dio Fatebenefratelli), Marinus A. Blankenstein(Amsterdam UMC Location Vrije Universiteit Amsterdam), Ralph N. Martins(Edith Cowan University), Abhay Moghekar(Johns Hopkins University), Bradley T. Hyman(Harvard University), Douglas Galasko(University of Minnesota), Cindy Soendersoe Knudsen(Aarhus University Hospital), Michael T. Heneka(University of Massachusetts Chan Medical School), Daniela Galimberti(University of Milan), Gunilla Dahlfors(Karolinska University Hospital), David M. Holtzman(Hope Center for Neurological Disorders), Daniel Kidd(Janssen (United States)), Hiroyuki Arai(Tohoku University), Khalid Iqbal(Leibniz Institute for Prevention Research and Epidemiology - BIPS), James Lui(Edith Cowan University), Elisabeth Kapaki(National and Kapodistrian University of Athens), Els Coart(Fujirebio (Belgium)), Elmar Kaiser(Heidelberg University), Neal E. Cutler(Worldwide Clinical Trials (United States)), Qiao‐Xin Li(The University of Melbourne), Thomas J. Montine(Stanford University), Sergio Bernardini(University of Rome Tor Vergata)
Cited by 412
Related Papers
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|Alzheimer s & Dementia|2011|18.9k
An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest
|NeuroImage|2006|14.1k
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|Alzheimer s & Dementia|2011|7.1k
Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
|Journal of Internal Medicine|2004|5k